nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR2B—Sorafenib—liver cancer	0.182	0.342	CbGbCtD
Mirtazapine—HTR2C—Sorafenib—liver cancer	0.118	0.223	CbGbCtD
Mirtazapine—CYP2C8—Sorafenib—liver cancer	0.0557	0.105	CbGbCtD
Mirtazapine—CYP1A2—Sorafenib—liver cancer	0.0431	0.0811	CbGbCtD
Mirtazapine—CYP2C9—Sorafenib—liver cancer	0.0388	0.0731	CbGbCtD
Mirtazapine—CYP2D6—Sorafenib—liver cancer	0.0355	0.0668	CbGbCtD
Mirtazapine—CYP3A4—Sorafenib—liver cancer	0.0226	0.0425	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—liver cancer	0.0216	0.0405	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—liver cancer	0.0137	0.0258	CbGbCtD
Mirtazapine—Asthenia—Sorafenib—liver cancer	0.00046	0.00148	CcSEcCtD
Mirtazapine—Mood swings—Epirubicin—liver cancer	0.000456	0.00147	CcSEcCtD
Mirtazapine—Lethargy—Doxorubicin—liver cancer	0.000455	0.00146	CcSEcCtD
Mirtazapine—Pruritus—Sorafenib—liver cancer	0.000453	0.00146	CcSEcCtD
Mirtazapine—Ataxia—Epirubicin—liver cancer	0.000453	0.00146	CcSEcCtD
Mirtazapine—Dehydration—Epirubicin—liver cancer	0.000448	0.00144	CcSEcCtD
Mirtazapine—Hyponatraemia—Doxorubicin—liver cancer	0.000448	0.00144	CcSEcCtD
Mirtazapine—Diplopia—Doxorubicin—liver cancer	0.000446	0.00143	CcSEcCtD
Mirtazapine—Osteoarthritis—Doxorubicin—liver cancer	0.000446	0.00143	CcSEcCtD
Mirtazapine—Liver function test abnormal—Epirubicin—liver cancer	0.000445	0.00143	CcSEcCtD
Mirtazapine—Dry skin—Epirubicin—liver cancer	0.000442	0.00142	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Epirubicin—liver cancer	0.00044	0.00142	CcSEcCtD
Mirtazapine—Affect lability—Doxorubicin—liver cancer	0.000439	0.00141	CcSEcCtD
Mirtazapine—Migraine—Doxorubicin—liver cancer	0.000439	0.00141	CcSEcCtD
Mirtazapine—Diarrhoea—Sorafenib—liver cancer	0.000438	0.00141	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000434	0.0014	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000434	0.0014	CcSEcCtD
Mirtazapine—Face oedema—Doxorubicin—liver cancer	0.00043	0.00138	CcSEcCtD
Mirtazapine—Gastritis—Epirubicin—liver cancer	0.000426	0.00137	CcSEcCtD
Mirtazapine—Muscular weakness—Epirubicin—liver cancer	0.000425	0.00137	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000425	0.00137	CcSEcCtD
Mirtazapine—Dizziness—Sorafenib—liver cancer	0.000424	0.00136	CcSEcCtD
Mirtazapine—Mood swings—Doxorubicin—liver cancer	0.000422	0.00136	CcSEcCtD
Mirtazapine—Abdominal distension—Epirubicin—liver cancer	0.000419	0.00135	CcSEcCtD
Mirtazapine—Ataxia—Doxorubicin—liver cancer	0.000419	0.00135	CcSEcCtD
Mirtazapine—Influenza—Epirubicin—liver cancer	0.000416	0.00134	CcSEcCtD
Mirtazapine—Asthma—Epirubicin—liver cancer	0.000416	0.00134	CcSEcCtD
Mirtazapine—Dehydration—Doxorubicin—liver cancer	0.000415	0.00133	CcSEcCtD
Mirtazapine—Eosinophilia—Epirubicin—liver cancer	0.000412	0.00133	CcSEcCtD
Mirtazapine—Liver function test abnormal—Doxorubicin—liver cancer	0.000412	0.00132	CcSEcCtD
Mirtazapine—Dry skin—Doxorubicin—liver cancer	0.000409	0.00131	CcSEcCtD
Mirtazapine—Pancreatitis—Epirubicin—liver cancer	0.000408	0.00131	CcSEcCtD
Mirtazapine—Vomiting—Sorafenib—liver cancer	0.000407	0.00131	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000407	0.00131	CcSEcCtD
Mirtazapine—Angina pectoris—Epirubicin—liver cancer	0.000406	0.0013	CcSEcCtD
Mirtazapine—Rash—Sorafenib—liver cancer	0.000404	0.0013	CcSEcCtD
Mirtazapine—Dermatitis—Sorafenib—liver cancer	0.000404	0.0013	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000401	0.00129	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000401	0.00129	CcSEcCtD
Mirtazapine—Headache—Sorafenib—liver cancer	0.000401	0.00129	CcSEcCtD
Mirtazapine—Bronchitis—Epirubicin—liver cancer	0.0004	0.00129	CcSEcCtD
Mirtazapine—Pancytopenia—Epirubicin—liver cancer	0.000395	0.00127	CcSEcCtD
Mirtazapine—Gastritis—Doxorubicin—liver cancer	0.000394	0.00127	CcSEcCtD
Mirtazapine—Muscular weakness—Doxorubicin—liver cancer	0.000393	0.00126	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000393	0.00126	CcSEcCtD
Mirtazapine—Dysuria—Epirubicin—liver cancer	0.000389	0.00125	CcSEcCtD
Mirtazapine—Neutropenia—Epirubicin—liver cancer	0.000389	0.00125	CcSEcCtD
Mirtazapine—Abdominal distension—Doxorubicin—liver cancer	0.000388	0.00125	CcSEcCtD
Mirtazapine—Asthma—Doxorubicin—liver cancer	0.000385	0.00124	CcSEcCtD
Mirtazapine—Influenza—Doxorubicin—liver cancer	0.000385	0.00124	CcSEcCtD
Mirtazapine—Pollakiuria—Epirubicin—liver cancer	0.000385	0.00124	CcSEcCtD
Mirtazapine—Eosinophilia—Doxorubicin—liver cancer	0.000381	0.00123	CcSEcCtD
Mirtazapine—Nausea—Sorafenib—liver cancer	0.000381	0.00122	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Epirubicin—liver cancer	0.00038	0.00122	CcSEcCtD
Mirtazapine—Weight increased—Epirubicin—liver cancer	0.000379	0.00122	CcSEcCtD
Mirtazapine—Pancreatitis—Doxorubicin—liver cancer	0.000378	0.00121	CcSEcCtD
Mirtazapine—Weight decreased—Epirubicin—liver cancer	0.000377	0.00121	CcSEcCtD
Mirtazapine—Angina pectoris—Doxorubicin—liver cancer	0.000375	0.00121	CcSEcCtD
Mirtazapine—Pneumonia—Epirubicin—liver cancer	0.000373	0.0012	CcSEcCtD
Mirtazapine—Drowsiness—Epirubicin—liver cancer	0.000371	0.00119	CcSEcCtD
Mirtazapine—Bronchitis—Doxorubicin—liver cancer	0.000371	0.00119	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000368	0.00118	CcSEcCtD
Mirtazapine—Pancytopenia—Doxorubicin—liver cancer	0.000366	0.00118	CcSEcCtD
Mirtazapine—Jaundice—Epirubicin—liver cancer	0.000362	0.00116	CcSEcCtD
Mirtazapine—Stomatitis—Epirubicin—liver cancer	0.000362	0.00116	CcSEcCtD
Mirtazapine—Conjunctivitis—Epirubicin—liver cancer	0.000361	0.00116	CcSEcCtD
Mirtazapine—Urinary tract infection—Epirubicin—liver cancer	0.000361	0.00116	CcSEcCtD
Mirtazapine—Neutropenia—Doxorubicin—liver cancer	0.00036	0.00116	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—liver cancer	0.00036	0.00116	CcSEcCtD
Mirtazapine—Sweating—Epirubicin—liver cancer	0.000356	0.00114	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—liver cancer	0.000356	0.00114	CcSEcCtD
Mirtazapine—Haematuria—Epirubicin—liver cancer	0.000354	0.00114	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000352	0.00113	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Epirubicin—liver cancer	0.000351	0.00113	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—liver cancer	0.000351	0.00113	CcSEcCtD
Mirtazapine—Epistaxis—Epirubicin—liver cancer	0.00035	0.00113	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—liver cancer	0.000349	0.00112	CcSEcCtD
Mirtazapine—Sinusitis—Epirubicin—liver cancer	0.000348	0.00112	CcSEcCtD
Mirtazapine—Agranulocytosis—Epirubicin—liver cancer	0.000346	0.00111	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—liver cancer	0.000346	0.00111	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—liver cancer	0.000344	0.0011	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000341	0.0011	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—liver cancer	0.000339	0.00109	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—liver cancer	0.000335	0.00108	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—liver cancer	0.000335	0.00108	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—liver cancer	0.000334	0.00107	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—liver cancer	0.000334	0.00107	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—liver cancer	0.000334	0.00107	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—liver cancer	0.000333	0.00107	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—liver cancer	0.000332	0.00107	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—liver cancer	0.000331	0.00106	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—liver cancer	0.000329	0.00106	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—liver cancer	0.000329	0.00106	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—liver cancer	0.000328	0.00106	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—liver cancer	0.000328	0.00105	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—liver cancer	0.000327	0.00105	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000325	0.00104	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—liver cancer	0.000324	0.00104	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—liver cancer	0.000322	0.00104	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—liver cancer	0.000321	0.00103	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—liver cancer	0.000315	0.00101	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—liver cancer	0.000314	0.00101	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—liver cancer	0.000311	0.001	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—liver cancer	0.000311	0.000999	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—liver cancer	0.000309	0.000995	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—liver cancer	0.000309	0.000994	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—liver cancer	0.000308	0.000992	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—liver cancer	0.000307	0.000987	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—liver cancer	0.000306	0.000984	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—liver cancer	0.000305	0.000979	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—liver cancer	0.000304	0.000977	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—liver cancer	0.000302	0.000972	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—liver cancer	0.000302	0.000972	CcSEcCtD
Mirtazapine—Chills—Epirubicin—liver cancer	0.000299	0.000962	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—liver cancer	0.000298	0.000957	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—liver cancer	0.000295	0.000947	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—liver cancer	0.000292	0.000939	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—liver cancer	0.000292	0.000938	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—liver cancer	0.00029	0.000933	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—liver cancer	0.000288	0.000927	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—liver cancer	0.000288	0.000925	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—liver cancer	0.000286	0.00092	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—liver cancer	0.000286	0.000919	CcSEcCtD
Mirtazapine—Tension—Epirubicin—liver cancer	0.000285	0.000916	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—liver cancer	0.000284	0.000914	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—liver cancer	0.000282	0.000906	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—liver cancer	0.000281	0.000903	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—liver cancer	0.00028	0.0009	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—liver cancer	0.000277	0.00089	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—liver cancer	0.000275	0.000886	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—liver cancer	0.000272	0.000876	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—liver cancer	0.00027	0.000869	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—liver cancer	0.000269	0.000866	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—liver cancer	0.000268	0.000863	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—liver cancer	0.000268	0.000862	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—liver cancer	0.000267	0.000857	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—liver cancer	0.000265	0.000851	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—liver cancer	0.000263	0.000847	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—liver cancer	0.000263	0.000845	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—liver cancer	0.000262	0.000841	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—liver cancer	0.000261	0.000838	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—liver cancer	0.000261	0.000838	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—liver cancer	0.00026	0.000837	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—liver cancer	0.00026	0.000835	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—liver cancer	0.00026	0.000835	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—liver cancer	0.000256	0.000825	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—liver cancer	0.000255	0.00082	CcSEcCtD
Mirtazapine—Cough—Epirubicin—liver cancer	0.000253	0.000814	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—liver cancer	0.000251	0.000808	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—liver cancer	0.00025	0.000806	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—liver cancer	0.000249	0.000801	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—liver cancer	0.000248	0.000798	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—liver cancer	0.000247	0.000794	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—liver cancer	0.000247	0.000794	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—liver cancer	0.000247	0.000794	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—liver cancer	0.000247	0.000793	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—liver cancer	0.000246	0.000792	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000245	0.000789	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—liver cancer	0.000244	0.000785	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—liver cancer	0.000242	0.000779	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—liver cancer	0.000242	0.000777	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—liver cancer	0.000241	0.000776	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—liver cancer	0.000241	0.000774	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—liver cancer	0.00024	0.000773	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—liver cancer	0.000239	0.000768	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—liver cancer	0.000237	0.000763	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—liver cancer	0.000237	0.000761	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—liver cancer	0.000236	0.000759	CcSEcCtD
Mirtazapine—Infection—Epirubicin—liver cancer	0.000235	0.000757	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—liver cancer	0.000234	0.000753	CcSEcCtD
Mirtazapine—Shock—Epirubicin—liver cancer	0.000233	0.000749	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—liver cancer	0.000233	0.000748	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—liver cancer	0.000232	0.000747	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—liver cancer	0.000232	0.000746	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—liver cancer	0.000232	0.000745	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—liver cancer	0.000231	0.000743	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—liver cancer	0.00023	0.00074	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—liver cancer	0.000229	0.000736	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—liver cancer	0.000229	0.000735	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—liver cancer	0.000229	0.000735	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—liver cancer	0.000229	0.000735	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—liver cancer	0.000228	0.000732	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000227	0.00073	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—liver cancer	0.000226	0.000726	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—liver cancer	0.000226	0.000726	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—liver cancer	0.000224	0.000719	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—liver cancer	0.000221	0.000712	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—liver cancer	0.000221	0.00071	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—liver cancer	0.000219	0.000705	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—liver cancer	0.000218	0.0007	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000216	0.000694	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—liver cancer	0.000216	0.000693	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—liver cancer	0.000215	0.000691	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—liver cancer	0.000215	0.00069	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—liver cancer	0.000214	0.000689	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—liver cancer	0.000214	0.000688	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—liver cancer	0.000213	0.000684	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—liver cancer	0.000213	0.000684	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—liver cancer	0.000212	0.000681	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—liver cancer	0.000211	0.000679	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—liver cancer	0.00021	0.000677	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—liver cancer	0.000209	0.000672	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—liver cancer	0.000208	0.00067	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—liver cancer	0.000206	0.000662	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—liver cancer	0.000205	0.000658	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000204	0.000657	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—liver cancer	0.000204	0.000657	CcSEcCtD
Mirtazapine—Pain—Epirubicin—liver cancer	0.000202	0.000651	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—liver cancer	0.000202	0.000651	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.0002	0.000642	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—liver cancer	0.000198	0.000637	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—liver cancer	0.000197	0.000633	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—liver cancer	0.000195	0.000628	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—liver cancer	0.000195	0.000628	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—liver cancer	0.000195	0.000626	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—liver cancer	0.000194	0.000623	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—liver cancer	0.000193	0.00062	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—liver cancer	0.00019	0.000612	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000189	0.000608	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—liver cancer	0.000189	0.000607	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—liver cancer	0.000188	0.000605	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—liver cancer	0.000187	0.000603	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—liver cancer	0.000187	0.000603	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—liver cancer	0.000187	0.000602	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—liver cancer	0.000187	0.000602	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—liver cancer	0.000181	0.000581	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000179	0.000576	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—liver cancer	0.000174	0.000561	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—liver cancer	0.000174	0.00056	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—liver cancer	0.000173	0.000557	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—liver cancer	0.000173	0.000557	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—liver cancer	0.00017	0.000546	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—liver cancer	0.000168	0.000539	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—liver cancer	0.000162	0.000521	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—liver cancer	0.000161	0.000519	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—liver cancer	0.000157	0.000506	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—liver cancer	0.000157	0.000504	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—liver cancer	0.000155	0.000498	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—liver cancer	0.000151	0.000484	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—liver cancer	0.00015	0.000482	CcSEcCtD
Mirtazapine—Rash—Epirubicin—liver cancer	0.000149	0.00048	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—liver cancer	0.000149	0.00048	CcSEcCtD
Mirtazapine—Headache—Epirubicin—liver cancer	0.000148	0.000477	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—liver cancer	0.000145	0.000466	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—liver cancer	0.000141	0.000452	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—liver cancer	0.000139	0.000448	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—liver cancer	0.000138	0.000444	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—liver cancer	0.000138	0.000444	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—liver cancer	0.000137	0.000441	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—liver cancer	0.00013	0.000419	CcSEcCtD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—liver cancer	7.66e-06	4.86e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—liver cancer	7.64e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MAPK8—liver cancer	7.64e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—liver cancer	7.62e-06	4.83e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—liver cancer	7.61e-06	4.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	7.61e-06	4.83e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PIK3CA—liver cancer	7.59e-06	4.82e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.55e-06	4.79e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—liver cancer	7.49e-06	4.75e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—liver cancer	7.48e-06	4.75e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1B—liver cancer	7.48e-06	4.75e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—liver cancer	7.48e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PIK3CA—liver cancer	7.47e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—liver cancer	7.47e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—liver cancer	7.43e-06	4.72e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MAPK8—liver cancer	7.43e-06	4.72e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—liver cancer	7.41e-06	4.7e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—liver cancer	7.41e-06	4.7e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—liver cancer	7.4e-06	4.7e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	7.37e-06	4.68e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1B—liver cancer	7.36e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1B—liver cancer	7.35e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—liver cancer	7.34e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—liver cancer	7.34e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—liver cancer	7.34e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—liver cancer	7.34e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—liver cancer	7.32e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—MTHFR—liver cancer	7.32e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RAF1—liver cancer	7.31e-06	4.64e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—liver cancer	7.29e-06	4.62e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—liver cancer	7.28e-06	4.62e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—liver cancer	7.27e-06	4.61e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CG—liver cancer	7.26e-06	4.61e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—liver cancer	7.25e-06	4.6e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—liver cancer	7.23e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—liver cancer	7.22e-06	4.58e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	7.21e-06	4.58e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—liver cancer	7.21e-06	4.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—liver cancer	7.2e-06	4.57e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—liver cancer	7.2e-06	4.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—liver cancer	7.19e-06	4.56e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARA—liver cancer	7.18e-06	4.56e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—liver cancer	7.18e-06	4.56e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—liver cancer	7.17e-06	4.55e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—liver cancer	7.16e-06	4.54e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—liver cancer	7.15e-06	4.54e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—liver cancer	7.14e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MTOR—liver cancer	7.14e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	7.14e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	7.13e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JUN—liver cancer	7.12e-06	4.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—liver cancer	7.09e-06	4.5e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—liver cancer	7.07e-06	4.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—liver cancer	7.07e-06	4.48e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—liver cancer	7.06e-06	4.48e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—liver cancer	7.05e-06	4.48e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—liver cancer	7.03e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—liver cancer	7.02e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—liver cancer	7.02e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—liver cancer	7.02e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JUN—liver cancer	7.01e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—liver cancer	7.01e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—liver cancer	7.01e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JUN—liver cancer	7e-06	4.44e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—liver cancer	6.98e-06	4.43e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—liver cancer	6.96e-06	4.42e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—liver cancer	6.96e-06	4.41e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—liver cancer	6.95e-06	4.41e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—liver cancer	6.94e-06	4.41e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—liver cancer	6.93e-06	4.4e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—liver cancer	6.92e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—liver cancer	6.92e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—liver cancer	6.91e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1A—liver cancer	6.91e-06	4.38e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—liver cancer	6.88e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JUN—liver cancer	6.86e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HMOX1—liver cancer	6.86e-06	4.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—liver cancer	6.86e-06	4.35e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—liver cancer	6.83e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—liver cancer	6.82e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—liver cancer	6.82e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	6.82e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	6.81e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—liver cancer	6.81e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—liver cancer	6.8e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1A—liver cancer	6.8e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—liver cancer	6.79e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1A—liver cancer	6.78e-06	4.3e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—liver cancer	6.78e-06	4.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MAPK8—liver cancer	6.74e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—liver cancer	6.72e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—liver cancer	6.72e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	6.7e-06	4.25e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—liver cancer	6.68e-06	4.24e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—liver cancer	6.67e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	6.65e-06	4.22e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—liver cancer	6.65e-06	4.22e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MAPK8—liver cancer	6.63e-06	4.21e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	6.63e-06	4.21e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MAPK8—liver cancer	6.62e-06	4.2e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—liver cancer	6.62e-06	4.2e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—liver cancer	6.62e-06	4.2e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—liver cancer	6.62e-06	4.2e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—liver cancer	6.61e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—liver cancer	6.6e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—liver cancer	6.57e-06	4.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—liver cancer	6.56e-06	4.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—liver cancer	6.52e-06	4.14e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—liver cancer	6.52e-06	4.14e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—liver cancer	6.51e-06	4.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MAPK8—liver cancer	6.5e-06	4.12e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—liver cancer	6.49e-06	4.12e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—liver cancer	6.48e-06	4.11e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—liver cancer	6.47e-06	4.11e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.45e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—liver cancer	6.41e-06	4.07e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTM1—liver cancer	6.39e-06	4.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—liver cancer	6.39e-06	4.06e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—liver cancer	6.38e-06	4.05e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JUN—liver cancer	6.38e-06	4.05e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—liver cancer	6.35e-06	4.03e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—liver cancer	6.33e-06	4.02e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	6.33e-06	4.02e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—liver cancer	6.33e-06	4.02e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—liver cancer	6.32e-06	4.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—liver cancer	6.31e-06	4.01e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—liver cancer	6.3e-06	4e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—liver cancer	6.3e-06	4e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—liver cancer	6.3e-06	4e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—liver cancer	6.25e-06	3.96e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—liver cancer	6.22e-06	3.95e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—liver cancer	6.21e-06	3.94e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—liver cancer	6.2e-06	3.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	6.18e-06	3.92e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—liver cancer	6.16e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—liver cancer	6.16e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—liver cancer	6.15e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—liver cancer	6.15e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—liver cancer	6.12e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—liver cancer	6.11e-06	3.88e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—liver cancer	6.1e-06	3.87e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—liver cancer	6.06e-06	3.85e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP1A1—liver cancer	6.06e-06	3.85e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—liver cancer	6.05e-06	3.84e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—liver cancer	6.05e-06	3.84e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	6.03e-06	3.83e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—liver cancer	6.03e-06	3.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	6.02e-06	3.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	6e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—liver cancer	6e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—liver cancer	5.94e-06	3.77e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—liver cancer	5.94e-06	3.77e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—liver cancer	5.88e-06	3.73e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—liver cancer	5.84e-06	3.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—liver cancer	5.83e-06	3.7e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—liver cancer	5.79e-06	3.67e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—liver cancer	5.73e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—liver cancer	5.71e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—liver cancer	5.66e-06	3.59e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—liver cancer	5.65e-06	3.59e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—liver cancer	5.64e-06	3.58e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—liver cancer	5.63e-06	3.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—liver cancer	5.62e-06	3.57e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—liver cancer	5.62e-06	3.57e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—liver cancer	5.61e-06	3.56e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—liver cancer	5.6e-06	3.55e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—liver cancer	5.58e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	5.57e-06	3.54e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—liver cancer	5.56e-06	3.53e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARA—liver cancer	5.54e-06	3.52e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	5.54e-06	3.51e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—liver cancer	5.52e-06	3.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—liver cancer	5.52e-06	3.5e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—liver cancer	5.52e-06	3.5e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	5.51e-06	3.5e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	5.5e-06	3.49e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—liver cancer	5.48e-06	3.48e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—liver cancer	5.41e-06	3.43e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	5.36e-06	3.4e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—liver cancer	5.36e-06	3.4e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—liver cancer	5.36e-06	3.4e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—liver cancer	5.34e-06	3.39e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—liver cancer	5.33e-06	3.38e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—liver cancer	5.29e-06	3.36e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—liver cancer	5.24e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—liver cancer	5.23e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—liver cancer	5.21e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—liver cancer	5.2e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—liver cancer	5.2e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—liver cancer	5.19e-06	3.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—liver cancer	5.18e-06	3.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—liver cancer	5.13e-06	3.25e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—liver cancer	5.13e-06	3.25e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—liver cancer	5.12e-06	3.25e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	5.11e-06	3.25e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—liver cancer	5.1e-06	3.24e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—liver cancer	5.1e-06	3.23e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—liver cancer	5.01e-06	3.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—liver cancer	4.96e-06	3.15e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—liver cancer	4.9e-06	3.11e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—liver cancer	4.88e-06	3.1e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—liver cancer	4.86e-06	3.09e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—liver cancer	4.78e-06	3.04e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—liver cancer	4.77e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—liver cancer	4.75e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—liver cancer	4.74e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—liver cancer	4.74e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—liver cancer	4.73e-06	3e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—liver cancer	4.71e-06	2.99e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—liver cancer	4.7e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	4.68e-06	2.97e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—liver cancer	4.63e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—liver cancer	4.63e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—liver cancer	4.62e-06	2.93e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—liver cancer	4.58e-06	2.91e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—liver cancer	4.53e-06	2.88e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—liver cancer	4.52e-06	2.87e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—liver cancer	4.5e-06	2.86e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—liver cancer	4.5e-06	2.85e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—liver cancer	4.43e-06	2.81e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—liver cancer	4.42e-06	2.8e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—liver cancer	4.38e-06	2.78e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	4.35e-06	2.76e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—liver cancer	4.33e-06	2.75e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—liver cancer	4.3e-06	2.73e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—liver cancer	4.25e-06	2.7e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—liver cancer	4.24e-06	2.69e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—liver cancer	4.23e-06	2.68e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—liver cancer	4.21e-06	2.67e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—liver cancer	4.17e-06	2.65e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—liver cancer	4.15e-06	2.63e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—liver cancer	4.13e-06	2.62e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—liver cancer	4.12e-06	2.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—liver cancer	4.03e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—liver cancer	3.97e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—liver cancer	3.91e-06	2.48e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—liver cancer	3.9e-06	2.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—liver cancer	3.85e-06	2.45e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—liver cancer	3.83e-06	2.43e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—liver cancer	3.64e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—liver cancer	3.56e-06	2.26e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—liver cancer	3.39e-06	2.15e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—liver cancer	3.37e-06	2.14e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—liver cancer	3.36e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—liver cancer	2.87e-06	1.82e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—liver cancer	2.77e-06	1.76e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—liver cancer	2.75e-06	1.74e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—liver cancer	2.35e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—liver cancer	2.22e-06	1.41e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—liver cancer	1.81e-06	1.15e-05	CbGpPWpGaD
